Tech Forum: Chroniject Technology: A Solution to Long Acting Injectable Microsphere Formulation and Scale-Up Challenges

Oakwood's Chroniject technology provides a tunable long-acting injectable platform for a wide array of molecules and applications. Efficacious release profiles have been generated from as fast as two days to as long as one year.

Oakwood's Chroniject technology provides the platform for scale-up of the formulation process, allowing for the critical quality attributes of the long-acting injectable formulations to be maintained from initial feasibility batch sizes in the gram-scale to clinical and commercial batch sizes in the multi-kilogram scale.

This session will demonstrate the feasibility testing and scale up of multiple API types, including small molecules and a peptide. Multiple case studies will demonstrate a unique scale up approach, overcoming common scale up challenges and how to prevent them. A full review of the development and scale up considerations will be shown, along with Oakwood's core technology capabilities.